MTOR and neoplasm: According to their findings, miR-27a inhibited AMP-activated protein kinase, increased mTOR signaling, and collaborated with oncogenes and tumor cell metabolic regulators to create an aerobic glycolytic metabolism that supported biomass generation, unrestrained growth, and chemoresistance.